Viveve Medical Inc
Change company Symbol lookup
Select an option...
VIVE Viveve Medical Inc
CIDM Cinedigm Corp
SMG Scotts Miracle-Gro Co
CODX Co-Diagnostics Inc
LQDA Liquidia Technologies Inc
VSLR Vivint Solar Inc
MUR Murphy Oil Corp
BP BP PLC
ABBV Abbvie Inc
CVE Cenovus Energy Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.

Closing Price
$0.568
Day's Change
0.0068 (1.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.5825
Day's Low
0.55
Volume
(Average)
Volume:
604,649

10-day average volume:
652,301
604,649

Display:

Providers:

UpdateCancel
6 providers
June 29, 2020
Viveve Medical Announces Adjournment of Annual Meeting

Meeting scheduled to reconvene July 22, 2020 at 10:30 AM Eastern Time ENGLEWOOD, CO / ACCESSWIRE / June 29, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it has...(Accesswire)

May 14, 2020
Viveve Reports First Quarter 2020 Financial Results and Provides Corporate Update

ENGLEWOOD, CO / ACCESSWIRE / May 14, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today reported financial results for the quarter ended March 31, 2020, and will provide a corporate...(Accesswire)

May 07, 2020
Viveve to Host Conference Call to Provide Corporate Update and First Quarter 2020 Financial Results on May 14, 2020

ENGLEWOOD, CO / ACCESSWIRE / May 7, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will provide a corporate update and report its first quarter 2020 financial...(Accesswire)

April 17, 2020
Viveve Announces Update to Corporate Strategy

Reconfirms plans for near-term focus on Stress Urinary Incontinence clinical strategy Announces plans to further reduce operating expenses and cash burn rate Strengthens balance sheet through warrant exercise for approximately $3 million in proceeds (Accesswire)

Viveve Announces Exercise of Warrants for $3 Million Gross Proceeds

ENGLEWOOD, CO / ACCESSWIRE / April 17, 2020 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it has entered into agreements with several institutional and...(Accesswire)

April 16, 2020
Viveve Announces Approval of Viveve 2.0 System in Canada

Viveve 2.0 System now available throughout North America, Asia, and over 30 European countries ENGLEWOOD, CO / ACCESSWIRE / April 16, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today...(Accesswire)

April 15, 2020
Viveve Resubmits U.S. Investigational Device Exemption to FDA to Conduct New PURSUIT Trial for Improvement of Stress Urinary Incontinence

Proposed pivotal trial reinforces the company's strategic pursuit of label expansion for Cryogen-cooled, Monopolar Radiofrequency (CMRF) technology in SUI indication ENGLEWOOD, CO / ACCESSWIRE / April 15, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a...(Accesswire)

April 09, 2020
Viveve Announces Topline Results from Pivotal U.S. VIVEVE II Trial for Improvement of Sexual Function in Women

ENGLEWOOD, CO / ACCESSWIRE / April 9, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced topline results from the VIVEVE II clinical trial. VIVEVE II is a multicenter...(Accesswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.